|
CRK expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.559610E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.248400E-01 |
| Normal-vs-Stage2 |
5.006400E-02 |
| Normal-vs-Stage3 |
7.84919999999856E-05 |
| Normal-vs-Stage4 |
8.31250000000727E-05 |
| Stage1-vs-Stage2 |
3.892200E-02 |
| Stage1-vs-Stage3 |
3.54530000000741E-05 |
| Stage1-vs-Stage4 |
9.6513999999992E-05 |
| Stage2-vs-Stage3 |
4.675400E-01 |
| Stage2-vs-Stage4 |
2.272600E-01 |
| Stage3-vs-Stage4 |
4.425200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.502300E-02 |
| Normal-vs-AfricanAmerican |
6.677200E-03 |
| Normal-vs-Asian |
5.615400E-01 |
| Caucasian-vs-AfricanAmerican |
8.195700E-02 |
| Caucasian-vs-Asian |
2.830600E-01 |
| AfricanAmerican-vs-Asian |
9.963800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.744850E-03 |
| Normal-vs-Female |
6.612800E-01 |
| Male-vs-Female |
2.384400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.313800E-02 |
| Normal-vs-Age(41-60Yrs) |
1.154430E-01 |
| Normal-vs-Age(61-80Yrs) |
4.843700E-02 |
| Normal-vs-Age(81-100Yrs) |
1.239020E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.825180E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.731200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.937600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.826000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.529600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.711000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.222760E-01 |
| Normal-vs-Grade 2 |
5.106200E-01 |
| Normal-vs-Grade 3 |
3.959200E-04 |
| Normal-vs-Grade 4 |
2.17279999548126E-08 |
| Grade 1-vs-Grade 2 |
1.297580E-01 |
| Grade 1-vs-Grade 3 |
2.399900E-03 |
| Grade 1-vs-Grade 4 |
2.697600E-03 |
| Grade 2-vs-Grade 3 |
1.231770E-04 |
| Grade 2-vs-Grade 4 |
6.18130002738582E-09 |
| Grade 3-vs-Grade 4 |
7.535300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.552100E-02 |
| Normal-vs-ccB subtype |
2.66319999997489E-06 |
| ccA subtype-vs-ccB subtype |
1.24749988117401E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.102300E-02 |
| Normal-vs-N1 |
7.007500E-02 |
| N0-vs-N1 |
2.444400E-01 |
|
|
